Brokerage Firm Rating Update on McKesson Corporation (MCK)

McKesson Corporation (MCK) : The consensus on McKesson Corporation (MCK) based on 11 analyst recommendation on the company stock is 1.95, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 5 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 1 analyst believes that the stock is a Buy, which can produce decent returns in the future. 5 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.

McKesson Corporation (MCK) : Currently there are 9 street experts covering McKesson Corporation (MCK) stock. The most bullish and bearish price target for the stock is $230 and $172 respectively for the short term. The average price target of all the analysts comes to $206.11. The estimated standard deviation from the target is $16.41.


For the current week, the company shares have a recommendation consensus of Buy. Also, JP Morgan maintains its rating on McKesson Corporation (NYSE:MCK). The global brokerage major raises the current price target from $210 per share to $221 per share. Analysts at the JP Morgan have a current rating of Overweight on the shares. The rating by the firm was issued on August 9, 2016.

McKesson Corporation (NYSE:MCK): The stock opened at $184 and touched an intraday high of $186.28 on Wednesday. During the day, the stock corrected to an intraday low of $184, however, the bulls stepped in and pushed the price higher to close in the green at $184.96 with a gain of 0.15% for the day. The total traded volume for the day was 971,418. The stock had closed at $184.69 in the previous trading session.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.